Emerging data suggest Retatru tide , a dual stimulator targeting both the gut-brain axis and another hormone, may offer a promising development for weight treatment. Early human investigations have demonstrated substantial losses in visceral mass , potentially surpassing current weight-loss treatments. Nevertheless , further assessment is necessary